Are dietary supplements regulated by the FDA?

Yes — but not in the same way as prescription drugs. Under DSHEA (1994), dietary supplements are regulated as food, not drugs. The FDA requires manufacturers to register their facilities, comply with Good Manufacturing Practice regulations (21 CFR Part 111), and avoid making disease treatment claims on labels. However, the FDA does not approve supplements before sale or verify that products contain what their labels claim. The FDA's role is primarily reactive — investigating adverse events and conducting inspections after products are already in commerce.

Can the FDA recall supplements?

Yes. The FDA has authority to request or mandate recalls of dietary supplements that are found to be unsafe, adulterated, or misbranded. The FDA can also issue warning letters, seize products, and pursue injunctions against manufacturers. However, most supplement recalls are voluntary — initiated by the manufacturer after an FDA request or after the manufacturer identifies a quality problem. Mandatory FDA-ordered recalls of supplements occur but are less common than voluntary recalls. The absence of a recall history is not the same as verified safety.

What is DSHEA and why does it matter?

DSHEA — the Dietary Supplement Health and Education Act — is the 1994 federal law that established the current regulatory framework for dietary supplements in the United States. Before DSHEA, supplements were regulated under the Food, Drug, and Cosmetic Act as either food additives (requiring safety proof before marketing) or drugs (requiring FDA approval). DSHEA created a new category that allowed supplements to be sold without pre-market approval, placing responsibility for safety on manufacturers and limiting FDA's pre-market role. DSHEA also established the structure/function claim framework — allowing supplements to claim they 'support' physiological functions, but prohibiting disease treatment claims.

Are supplements tested before they are sold?

They are required to be tested internally by the manufacturer — but not by the FDA before sale. 21 CFR Part 111 requires supplement manufacturers to conduct identity testing on raw materials and finished product testing for identity, purity, strength, and composition. However, these tests are conducted and recorded internally, without pre-market FDA review. Independent third-party product testing — from organizations like NSF, USP, or Labdoor — provides external verification that what is on the label is in the bottle. These voluntary programs test against the manufacturer's interest, making their findings more credible than manufacturer-only testing.

What does 'FDA registered facility' actually mean?

'FDA registered facility' means the manufacturing facility has submitted a registration to the FDA as required under 21 CFR Part 1.5 for facilities that manufacture, process, pack, or hold food (including dietary supplements) for consumption in the United States. Registration is a legal prerequisite — not a quality verification. The FDA does not inspect facilities as part of the registration process. Registration does not mean the facility has been audited, found compliant, or certified to any quality standard. It simply means the facility has filed the required administrative notice with the agency. Do not confuse FDA facility registration with third-party quality certification.

Are Supplements FDA Approved? What DSHEA Actually Means for You

5 sectionsUpdated April 2026Reviewed by Dr. Brennan Commerford, D.C.

Quick Answer

Are dietary supplements FDA approved?

No. Dietary supplements are not FDA approved before they go to market. Under DSHEA (1994), supplements are regulated as food, not drugs. The FDA can act after a product is on the market if it is unsafe — but it does not pre-approve supplements for safety or efficacy.

The Short Answer: No

Dietary supplements sold in the United States are not FDA approved before they go to market. This is not a regulatory gap or an oversight — it is the explicit design of the legal framework that governs the supplement industry. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), dietary supplements are classified as a subcategory of food, not as drugs. The drug approval pathway — which requires pre-market demonstration of safety and efficacy through clinical trials before any product can be sold — simply does not apply.

Under DSHEA, responsibility for safety rests with the manufacturer before a product reaches the market, not with the FDA. Manufacturers are required to ensure their products are safe before sale, but they are not required to prove that safety to the FDA through any pre-market submission or approval process. The FDA's role is reactive: the agency can investigate a supplement after it reaches the market if there are reports of adverse events or if inspections reveal manufacturing violations. The FDA can issue warning letters, mandate recalls, and pursue enforcement actions — but these tools respond to problems after they exist in commerce, not before.

This structure means that the FDA's imprimatur does not exist for dietary supplements in the way it does for prescription drugs or medical devices. The phrase "FDA approved" on a supplement label would be misleading — not because the manufacturer is being dishonest about the product's quality, but because the FDA simply does not run an approval process that supplements can pass through. What supplements can legitimately claim is compliance with FDA GMP regulations (21 CFR Part 111) and registration with the FDA as a manufacturing facility — both of which are legal requirements, not badges of distinction.

DSHEA 1994, Pub. L. 103-41721 CFR Part 111

What the FDA Actually Does (and Doesn't Do)

The FDA does have a meaningful regulatory role in the supplement industry — it simply operates differently from the drug approval model that most consumers intuitively assume applies. Understanding what the FDA actually does, and what it explicitly does not do, is essential for evaluating any supplement's regulatory standing.

**What the FDA does:** - Requires facility registration (21 CFR Part 1.5) - Requires GMP compliance (21 CFR Part 111) - Monitors adverse event reports - Can issue warning letters and recalls after a product is on the market

**What the FDA does not do:** - Test supplements before sale - Verify label accuracy before products reach shelves - Approve supplements for safety or efficacy - Certify manufacturing quality

The practical implication: "FDA registered facility" on a supplement label confirms that the facility has complied with the legal requirement to register. It says nothing about the quality, safety, or accuracy of any specific product made there.

21 CFR Part 1.521 CFR Part 111FDA: Dietary Supplement Labeling Guide

GMP Requirements: The Legal Minimum Explained

Good Manufacturing Practice (GMP) regulations for dietary supplements — codified in 21 CFR Part 111 — represent the legal floor for supplement manufacturing in the United States. Understanding what GMP actually requires, and what it doesn't, clarifies why GMP compliance is necessary but not sufficient as a quality signal.

GMP requires four things at a minimum: verify every ingredient is what the supplier claims before it enters production; document exactly how each product is made and follow that record every time; test finished products before they leave the facility; and investigate every consumer complaint that could signal a quality problem.

These are substantive requirements. A facility that genuinely complies with all of them is operating at a meaningfully higher standard than a facility that does not. The critical limitation is that GMP compliance is, at its core, self-reported. The FDA does not certify facilities as GMP-compliant before they begin producing. A manufacturer can print "manufactured in a GMP-compliant facility" on every bottle without any third party having verified that claim. The FDA's inspection program is the primary external check — and as documented by FDA inspection data, a substantial proportion of supplement manufacturers have had one or more GMP violations identified during inspections.

GMP compliance is the legal requirement. It is not a ceiling — it is a floor. The question for discerning consumers is not whether a facility claims GMP compliance, but whether that compliance has been independently verified, and to what standard. That is the role that voluntary third-party certification programs fill.

21 CFR Part 111PMID: 23552723

The Gap Between Law and Practice

The distance between what supplement GMP regulations require and what FDA inspection data shows is occurring in practice is significant. Understanding this gap is not an indictment of the supplement industry in its entirety — many manufacturers operate with genuine rigor — but it is essential context for understanding why voluntary third-party certification carries meaningful signal.

73% of supplement manufacturing facilities inspected by the FDA had at least one GMP violation, according to a 2013 analysis in JAMA Internal Medicine by Cohen and colleagues examining FDA warning letters and 483 inspection observations. The most common violations were in areas that directly affect product quality and consumer safety: failures in identity testing of raw materials (meaning ingredients were not verified to be what suppliers claimed), inadequate written procedures, and insufficient master manufacturing records that would allow investigation of any quality problem. These are not paperwork violations — they are the foundational controls that GMP was designed to mandate.

A structural limitation compounds the inspection gap: the FDA simply does not have the resources to inspect every facility frequently. The supplement industry includes thousands of manufacturers, contract manufacturers, and co-packers. Even well-intentioned, resourced inspection programs will leave many facilities with gaps of several years between visits. A facility that has never been inspected cannot credibly claim to be verified compliant — it has simply never been evaluated. Self-declared compliance in this context is largely unverifiable from the outside.

Independent third-party certification programs — particularly NSF International's NSF/ANSI 455-2 standard — exist precisely to fill this verification gap. Rather than waiting for the FDA's reactive inspection cycle, certified facilities undergo annual audits from independent auditors who evaluate compliance across the same and additional regulatory requirements on a predictable, verified schedule.

PMID: 23552723FDA: Dietary Supplements Regulatory Framework

How Third-Party Certification Fills the Gap

Voluntary third-party certification programs for dietary supplement manufacturers address the core limitation of the FDA's framework: the absence of mandatory pre-market facility verification. These programs — operated by organizations like NSF International and US Pharmacopeia (USP) — have accredited auditors physically inspect facilities, review records, assess processes, and issue graded evaluations on defined schedules. The result is an independent, current, verifiable quality signal that self-declared GMP compliance cannot provide.

NSF International's NSF/ANSI 455-2 standard — which replaced the older NSF/ANSI 173 in 2022 — is the most comprehensive dietary supplement manufacturing standard currently available. It is ANSI-accredited, meaning the standard itself was developed through a rigorous consensus process. The standard covers five federal regulatory domains simultaneously: 21 CFR Part 111 (supplement-specific GMP), 21 CFR Part 117 (preventive controls for human food), 21 CFR Part 11 (electronic records and electronic signatures — ensuring that audit trails cannot be altered), 21 CFR Part 1.5 Subpart L (facility registration), and 21 CFR Part 1.9 Subpart O (supply chain traceability). Annual audits with a risk-based approach identify nonconformances, which are graded by severity. Facilities receive a letter grade (A+ through C) based on the number and severity of nonconformances — with A+ representing the fewest and least severe findings.

USP's Verified Mark program operates differently: it focuses on product-level testing rather than facility-level auditing. A product carrying the USP Verified Mark has been tested for ingredient identity, potency, purity, and dissolution by USP's independent laboratories. This is a meaningful signal for the specific product tested — but it does not cover the manufacturing process controls that govern every batch. For facility-level process assurance, NSF/ANSI 455-2 is the more comprehensive standard. For a full comparison of these programs, see our NSF vs USP vs GMP guide.

NSF/ANSI 455-2:2022USP Dietary Supplements Compendium

Start My Formula

Frequently Asked Questions

Are dietary supplements regulated by the FDA?: Yes — but not in the same way as prescription drugs. Under DSHEA (1994), dietary supplements are regulated as food, not drugs. The FDA requires manufacturers to register their facilities, comply with Good Manufacturing Practice regulations (21 CFR Part 111), and avoid making disease treatment claims on labels. However, the FDA does not approve supplements before sale or verify that products contain what their labels claim. The FDA's role is primarily reactive — investigating adverse events and conducting inspections after products are already in commerce.
Can the FDA recall supplements?: Yes. The FDA has authority to request or mandate recalls of dietary supplements that are found to be unsafe, adulterated, or misbranded. The FDA can also issue warning letters, seize products, and pursue injunctions against manufacturers. However, most supplement recalls are voluntary — initiated by the manufacturer after an FDA request or after the manufacturer identifies a quality problem. Mandatory FDA-ordered recalls of supplements occur but are less common than voluntary recalls. The absence of a recall history is not the same as verified safety.
What is DSHEA and why does it matter?: DSHEA — the Dietary Supplement Health and Education Act — is the 1994 federal law that established the current regulatory framework for dietary supplements in the United States. Before DSHEA, supplements were regulated under the Food, Drug, and Cosmetic Act as either food additives (requiring safety proof before marketing) or drugs (requiring FDA approval). DSHEA created a new category that allowed supplements to be sold without pre-market approval, placing responsibility for safety on manufacturers and limiting FDA's pre-market role. DSHEA also established the structure/function claim framework — allowing supplements to claim they 'support' physiological functions, but prohibiting disease treatment claims.
Are supplements tested before they are sold?: They are required to be tested internally by the manufacturer — but not by the FDA before sale. 21 CFR Part 111 requires supplement manufacturers to conduct identity testing on raw materials and finished product testing for identity, purity, strength, and composition. However, these tests are conducted and recorded internally, without pre-market FDA review. Independent third-party product testing — from organizations like NSF, USP, or Labdoor — provides external verification that what is on the label is in the bottle. These voluntary programs test against the manufacturer's interest, making their findings more credible than manufacturer-only testing.
What does 'FDA registered facility' actually mean?: 'FDA registered facility' means the manufacturing facility has submitted a registration to the FDA as required under 21 CFR Part 1.5 for facilities that manufacture, process, pack, or hold food (including dietary supplements) for consumption in the United States. Registration is a legal prerequisite — not a quality verification. The FDA does not inspect facilities as part of the registration process. Registration does not mean the facility has been audited, found compliant, or certified to any quality standard. It simply means the facility has filed the required administrative notice with the agency. Do not confuse FDA facility registration with third-party quality certification.

References

DSHEA 1994, Pub. L. 103-417
21 CFR Part 111
21 CFR Part 1.5
FDA: Dietary Supplement Labeling Guide
PMID: 23552723 PubMed
FDA: Dietary Supplements Regulatory Framework
NSF/ANSI 455-2:2022
USP Dietary Supplements Compendium

FormulaForge formulates and sells supplements containing the ingredients discussed on this page. Our formulary recommendations are based on peer-reviewed bioavailability research. All cited studies are independently verifiable.